Pancreatic Cancer Research

ResearcherSheng Jing HospitalNo recent work listed

Xinlu Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4324-2504; OpenAlex author ID A5053621774. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 2 papers · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 7

  1. New thoughts and findings on invasion and metastasis of pancreatic ductal adenocarcinoma (PDAC) from comparative proteomics: multi-target therapy. Co-author DOI 10.1007/s12094-023-03106-8↗
  2. Exosomal Tenascin-c Induces Proliferation and Invasion of Pancreatic Cancer Cells by WNT Signaling [Retraction]. Co-author DOI 10.2147/ott.s393902↗
  3. Role of exosomal microRNA-125b-5p in conferring the metastatic phenotype among pancreatic cancer cells with different potential of metastasis. Co-author DOI 10.1016/j.lfs.2020.117857↗
  4. ITGA6 and RPSA synergistically promote pancreatic cancer invasion and metastasis via PI3K and MAPK signaling pathways. Co-author DOI 10.1016/j.yexcr.2019.03.022↗
  5. Exosomal Tenascin-c induces proliferation and invasion of pancreatic cancer cells by WNT signaling. Co-author DOI 10.2147/ott.s192218↗
  6. Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics. Co-author DOI 10.2147/ott.s162470↗
  7. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathw… Co-author DOI 10.3727/096504018x15166223632406↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peng Liu · 6 shared papers, 2018–2022 · strength 0.71
  2. Xiaodong Tan · 6 shared papers, 2018–2022 · strength 0.71
  3. Songying Qian · 3 shared papers, 2018–2022 · strength 0.42
  4. Na Li · 1 shared paper, 2023 · strength 0.39
  5. Yunhao Wu · 2 shared papers, 2019–2022 · strength 0.33
  6. Yunhao Wu · 3 shared papers, 2018–2020 · strength 0.30
  7. Mengwei Wu · 2 shared papers, 2019–2020 · strength 0.20
  8. Haoyi Jin · 2 shared papers, 2019–2020 · strength 0.20
  9. Yifan Yang · 2 shared papers, 2019–2020 · strength 0.20
  10. Xiaobo Zhang · 1 shared paper, 2018 · strength 0.10
  11. Yukui Zhang · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.